Air Pollution Linked to Respiratory and Cardiovascular Deaths
|
By HospiMedica International staff writers Posted on 21 Feb 2017 |
A new study confirms that as exposure to urban fine particulate air pollution increases, so does deaths from cardiovascular and respiratory diseases.
Researchers at Fudan University, the Chinese Center for Disease Control and Prevention, Emory University, and other institutions conducted an epidemiological study in 272 Chinese cities between 2013 and 2015 in order to evaluate short-term associations between fine particulate (PM2.5) and daily cause-specific mortality. City-specific effects of PM2.5, exposure-response relationship curves, and potential effect modifiers were also evaluated.
The results showed that the average of annual-mean PM2.5 concentrations in each city was 56 µg/m3, well above the World Health Organization (WHO) air quality guidelines of 10 µg/m3; each additional 10 µg/m3 increase in daily PM2.5 concentrations was associated with increments of 0.22% in mortality from total non-accidental causes, 0.27% from cardiovascular diseases, 0.39% from hypertension, 0.30% from coronary heart disease (CAD), 0.23% from stroke, 0.29% from respiratory diseases, and 0.38% from chronic obstructive pulmonary disease (COPD).
Other findings were that mortality was significantly higher among people age 75 and older, and among those with lower levels of education. The study suggests a weaker association between PM2.5 and mortality than studies conducted in Europe and North America, which could indicate that particulate pollution contents in China may be less toxic than those in other countries, possibly because crustal dust from arid lands and construction make up more of PM2.5 in China. The study was published on February 9, 2017, in the American Journal of Respiratory and Critical Care Medicine.
“Our findings may be helpful to formulate public health policies and ambient air quality standards in developing countries to reduce the disease burden associated with PM2.5 air pollution,” said study co-author professor of public health Haidong Kan, MD, of Fudan University. “Further massive investigations, especially looking at the long-term effect studies, are needed to confirm our results and to identify the most toxic components of PM2.5 in China.”
Researchers at Fudan University, the Chinese Center for Disease Control and Prevention, Emory University, and other institutions conducted an epidemiological study in 272 Chinese cities between 2013 and 2015 in order to evaluate short-term associations between fine particulate (PM2.5) and daily cause-specific mortality. City-specific effects of PM2.5, exposure-response relationship curves, and potential effect modifiers were also evaluated.
The results showed that the average of annual-mean PM2.5 concentrations in each city was 56 µg/m3, well above the World Health Organization (WHO) air quality guidelines of 10 µg/m3; each additional 10 µg/m3 increase in daily PM2.5 concentrations was associated with increments of 0.22% in mortality from total non-accidental causes, 0.27% from cardiovascular diseases, 0.39% from hypertension, 0.30% from coronary heart disease (CAD), 0.23% from stroke, 0.29% from respiratory diseases, and 0.38% from chronic obstructive pulmonary disease (COPD).
Other findings were that mortality was significantly higher among people age 75 and older, and among those with lower levels of education. The study suggests a weaker association between PM2.5 and mortality than studies conducted in Europe and North America, which could indicate that particulate pollution contents in China may be less toxic than those in other countries, possibly because crustal dust from arid lands and construction make up more of PM2.5 in China. The study was published on February 9, 2017, in the American Journal of Respiratory and Critical Care Medicine.
“Our findings may be helpful to formulate public health policies and ambient air quality standards in developing countries to reduce the disease burden associated with PM2.5 air pollution,” said study co-author professor of public health Haidong Kan, MD, of Fudan University. “Further massive investigations, especially looking at the long-term effect studies, are needed to confirm our results and to identify the most toxic components of PM2.5 in China.”
Latest Critical Care News
- Ingestible Capsule Monitors Intestinal Inflammation
- Wireless Implantable Sensor Enables Continuous Endoleak Monitoring
- Pulse Oximeter Index Offers Non-Invasive Guides for Fluid Therapy
- Wearable Patch for Early Skin Cancer Detection to Reduce Unnecessary Biopsies
- 'Universal' Kidney to Match Any Blood Type
- Light-Based Technology to Measure Brain Blood Flow Could Diagnose Stroke and TBI
- AI Heart Attack Risk Assessment Tool Outperforms Existing Methods
- Smartphone Imaging System Enables Early Oral Cancer Detection
- Swallowable Pill-Sized Bioprinter Treats GI Tract Injuries

- Personalized Brain “Pacemakers” Could Help Patients with Hard-To-Treat Epilepsy
- Microscopic DNA Flower Robots to Enable Precision Medicine Delivery
- Origami Robots to Deliver Medicine Less Invasively and More Effectively
- Improved Cough-Detection Technology Aids Health Monitoring
- AI Identifies Children in ER Likely to Develop Sepsis Within 48 Hours
- New Radiofrequency Therapy Slows Glioblastoma Growth
- Battery-Free Wireless Multi-Sensing Platform Revolutionizes Pressure Injury Detection
Channels
Surgical Techniques
view channel
Robotic Assistant Delivers Ultra-Precision Injections with Rapid Setup Times
Age-related macular degeneration (AMD) is a leading cause of blindness worldwide, affecting nearly 200 million people, a figure expected to rise to 280 million by 2040. Current treatment involves doctors... Read more
Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
Intracerebral hemorrhage, a type of stroke caused by bleeding deep within the brain, remains one of the most challenging neurological emergencies to treat. Accounting for about 15% of all strokes, it carries... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







